Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

被引：0
|
作者：
Rossana Tallerico
Costanza M Cristiani
Mariaelena Capone
Gabriele Madonna
Domenico Mallardo
Ester Simeone
Andrea Dominijanni
Antonio M Grimaldi
Francesco Colucci
Paolo A Ascierto
Ennio Carbone
机构：
[1] University "Magna Graecia" of Catanzaro,Tumorimmunology and Immunopathology Laboratory, Department of Experimental and Clinic Medicine
[2] Istituto Nazionale Tumori Fondazione "G. Pascale",Melanoma. CancerImmunotherapy and Innovative Therapy Unit
[3] Immunohaematological Transfusion Medicine Centre “Pugliese-Ciaccio” Hospital of Catanzaro,Department of Obstetrics and Gynaecology
[4] University of Cambridge Clinical School,Department of Microbiology Cell and Tumorbiology (MTC)
[5] Karolinska Institutet,undefined
来源：
Journal of Translational Medicine | / 13卷 / Suppl 1期
关键词：
Melanoma; Metastatic Melanoma; Melanoma Patient; Ipilimumab; Cell Immune Response;
D O I：
10.1186/1479-5876-13-S1-O8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Ipilimumab In Previously Treated Patients with Advanced Melanoma
    Sanford, Mark
    BIODRUGS, 2012, 26 (03) : 185 - 193
  • [22] Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab
    Damuzzo, V.
    Solito, S.
    Pinton, L.
    Carrozzo, E.
    Valpione, S.
    Pigozzo, J.
    Giancristofaro, R. Arboretti
    Chiarion-Sileni, V.
    Mandruzzato, S.
    ONCOIMMUNOLOGY, 2016, 5 (12):
  • [23] Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab
    Yana G. Najjar
    Fei Ding
    Yan Lin
    Robert VanderWeele
    Lisa H. Butterfield
    Ahmad A. Tarhini
    Journal of Translational Medicine, 15
  • [24] Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab
    Najjar, Yana G.
    Ding, Fei
    Lin, Yan
    VanderWeele, Robert
    Butterfield, Lisa H.
    Tarhini, Ahmad A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [25] Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients
    Lee, Hansol
    Quek, Camelia
    Silva, Ines
    Tasker, Annie
    Batten, Marcel
    Rizos, Helen
    Lim, Su Yin
    Gide, Tuba Nur
    Shang, Ping
    Attrill, Grace H.
    Madore, Jason
    Edwards, Jarem
    Carlino, Matteo S.
    Guminski, Alexander
    Saw, Robyn P. M.
    Thompson, John F.
    Ferguson, Peter M.
    Palendira, Umaimainthan
    Menzies, Alexander M.
    Long, Georgina V.
    Scolyer, Richard A.
    Wilmott, James S.
    ONCOIMMUNOLOGY, 2019, 8 (02):
  • [26] Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy
    Tímea Balatoni
    Anita Mohos
    Eszter Papp
    Tímea Sebestyén
    Gabriella Liszkay
    Judit Oláh
    Anita Varga
    Zsuzsanna Lengyel
    Gabriella Emri
    István Gaudi
    Andrea Ladányi
    Cancer Immunology, Immunotherapy, 2018, 67 : 141 - 151
  • [27] Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
    Wistuba-Hamprecht, Kilian
    Martens, Alexander
    Heubach, Florian
    Romano, Emanuela
    Foppen, Marnix Geukes
    Yuan, Jianda
    Postow, Michael
    Wong, Phillip
    Mallardo, Domenico
    Schilling, Bastian
    Di Giacomo, Anna Maria
    Khammari, Amir
    Dreno, Brigitte
    Maio, Michele
    Schadendorf, Dirk
    Ascierto, Paolo A.
    Wolchok, Jedd D.
    Blank, Christian U.
    Garbe, Claus
    Pawelec, Graham
    Weide, Benjamin
    EUROPEAN JOURNAL OF CANCER, 2017, 73 : 61 - 70
  • [28] Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy
    Balatoni, Timea
    Mohos, Anita
    Papp, Eszter
    Sebestyen, Timea
    Liszkay, Gabriella
    Olah, Judit
    Varga, Anita
    Lengyel, Zsuzsanna
    Emri, Gabriella
    Gaudi, Istvan
    Ladanyi, Andrea
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (01) : 141 - 151
  • [29] Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
    Maio, M.
    Danielli, R.
    Chiarion-Sileni, V.
    Pigozzo, J.
    Parmiani, G.
    Ridolfi, R.
    De Rosa, F.
    Del Vecchio, M.
    Di Guardo, L.
    Queirolo, P.
    Picasso, V.
    Marchetti, P.
    De Galitiis, F.
    Mandala, M.
    Guida, M.
    Simeone, E.
    Ascierto, P. A.
    ANNALS OF ONCOLOGY, 2013, 24 (11) : 2911 - 2915
  • [30] Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery
    Tazi, Karim
    Hathaway, Amanda
    Chiuzan, Cody
    Shirai, Keisuke
    CANCER MEDICINE, 2015, 4 (01): : 1 - 6
12345